Odyssey HealthCare Announces Record Date And Meeting Date For Special Meeting Of Stockholders
Odyssey HealthCare, Inc. (NASDAQ: ODSY) today announced that it has established a record date and a meeting date for a special meeting of its stockholders. At the special meeting, stockholders of record will consider and vote upon a proposal to approve the merger transaction as a result of which Odyssey would become a wholly owned subsidiary of Gentiva Health Services, Inc. (NASDAQ: GTIV), pursuant to the Agreement and Plan of Merger, dated as of May 23, 2010, between Odyssey and Gentiva.
Odyssey stockholders of record at the close of business on Friday, July 2, 2010, will be entitled to notice of the special meeting and to vote at the special meeting. The special meeting will be held on Monday, August 9, 2010, at 8:00 a.m. Central Time, at Odyssey’s principal offices located at 717 North Harwood Street, Suite 1600, Dallas, Texas 75201.
The “go-shop” process, conducted by Odyssey with the assistance of Goldman, Sachs & Co., Odyssey’s financial advisor in connection with the merger, ended on June 22, 2010, at 11:59 p.m. (Central Time). During the “go-shop” period, Goldman Sachs held discussions on behalf of Odyssey with potential buyers, but did not receive any alternative acquisition proposals. Odyssey continues to work with Gentiva to complete the merger.
The transaction is expected to close during the month of August, subject to the satisfaction of standard closing conditions, including approval by Odyssey’s stockholders.About Odyssey HealthCare, Inc. Based in Dallas, Texas, Odyssey is one of the largest providers of hospice care in the country in terms of both average daily patient census and number of locations. Odyssey seeks to improve the quality of life of terminally ill patients and their families by providing care directed at managing pain and other discomforting symptoms and by addressing the psychosocial and spiritual needs of patients and their families.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV